AVTX
Avalo Therapeutics Inc
NASDAQ: AVTX · HEALTHCARE · BIOTECHNOLOGY
$7.17
-3.63% today
Updated 2026-10-30
Market cap
$604.41M
P/E ratio
—
P/S ratio
10,244.24x
EPS (TTM)
$-4.31
Dividend yield
—
52W range
$11 – $24
Volume
1.8M
Avalo Therapeutics Inc (AVTX) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
—
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
—
Most recent quarter
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|